OTC and metabolic dysfunction-associated steatotic liver disease: Thus, it is evident (i) that NAFLD is associated with the upregulation of CPS1 and OTC expression when compared with non-NAFLD hepatocytes and (ii) that the expression of urea cycle enzymes increases further upon inflammatory exacerbation of the disease.